VF
IPSC icon

Virtu Financial’s Century Therapeutics IPSC Stock Holding History

Virtu Financial’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,018
Closed -$47K – 1725
2023
Q4 		$47K Buy
+14,018
New +$25.5K ﹤0.01% 1182
2023
Q1 		– Sell
-15,038
Closed -$77K – 1778
2022
Q4 		$77K Buy
+15,038
New +$142K 0.01% 1011

Other funds holding IPSC

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Virtu Financial's IPSC Position: Q1 2024 in Review

Virtu Financial sold out of Century Therapeutics (IPSC) in Q1 2024, closing a stake of 14,018 shares — an estimated $47K sold.

Virtu Financial first reported a position in IPSC in Q4 2022 and held it in 2 quarters. The position peaked at $77K in Q4 2022. 67 funds tracked by Wall St. Rank hold IPSC as of Q1 2024.

  • Virtu Financial reported no remaining Century Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 14,018 Century Therapeutics shares in Q1 2024, an estimated $47K.
  • Virtu Financial first reported a position in Century Therapeutics in Q4 2022 and held it in 2 quarters.
  • Virtu Financial's Century Therapeutics position peaked at $77K in Q4 2022.
  • 67 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.